Bristol-Myers Squibb extended its collaboration with Ambit Biosciences for the discovery and development of kinase inhibitors. Ambit will use its KinomeScan™ technology to screen Bristol-Myers Squibb's kinase-focused library.
Bristol-Myers Squibb extended its collaboration with Ambit Biosciences for the discovery and development of kinase inhibitors. Ambit will use its KinomeScan™ technology to screen Bristol-Myers Squibb's kinase-focused library.
